News from other sources

Technology

23andMe is gauging interest in a $749 'premium' service that would offer deeper health data | CNBC

The genetics-testing company is looking into whether people would pay for a premium service for more detailed genetic sequencing. The service could cost $749—hundreds higher than what's currently the company's most expensive offering.

'A potent team': What Jack Stoddard brings to the Atul Gawande-led health venture | Stat

Stoddard has 25 years of experience in healthcare, including in companies that use data to steer patients towards high-value, lower-cost care.

Pharmaceuticals

Trump health chief meets with GOP lawmakers on lowering drug prices | The Hill

HHS secretary Alex Azar met with House Ways and Means Committee members to talk about cutting drug costs, including work by both the Trump administration and by Congress.

Amid EpiPen shortage, Walgreens teams up with drug company to offer free alternative | Chicago Tribune

Walgreens and Kaleo are partnering to bring the drugmaker's Auvi-Q epinephrine injectors to consumers, either in person, at Walgreens pharmacies, or by mail. Kaleo will cover the cost of the drug to people with private insurance.

In other news

Newly revealed emails raise fresh objections to Kavanaugh confirmation | The New York Times

"I am not sure that all legal scholars refer to Roe as the settled law of the land at the Supreme Court level since Court can always overrule its precedent, and three current Justices on the Court would do so," Kavanaugh wrote in an email during his time as a lawyer in the White House during the George W. Bush years.